About Gene Logic
Gene Logic is a company based in Gaithersburg (United States) founded in 1994. Gene Logic has raised $29 million across 2 funding rounds from investors including Goldman Sachs, Hambrecht & Quist and Oxford Bioscience Partners. Gene Logic operates in a competitive market with competitors including Human Longevity, GSK, Avidity Biosciences, Helix and Benchling, among others.
- Headquarter Gaithersburg, United States
- Stage Public
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Gene Logic Acquisition Corp.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$29 M (USD)
in 2 rounds
-
Latest Funding Round
$20 M (USD), Series B
Jul 16, 1997
-
Investors
Goldman Sachs
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Gene Logic
Gene Logic has successfully raised a total of $29M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $20 million completed in July 1997. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Gene Logic
Gene Logic has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Goldman Sachs, Hambrecht & Quist and Oxford Bioscience Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment banking services are delivered across multiple financial sectors.
|
Locked | Locked | Locked | |
|
Early stage VC firm investing in the US and Korea
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Gene Logic
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Gene Logic
Investment portfolio details for Gene Logic
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Gene Logic
Detailed financials for Gene Logic
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gene Logic Comparisons
Peer comparison for Gene Logic
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Gene Logic
Gene Logic operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Human Longevity, GSK, Avidity Biosciences, Helix and Benchling, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomics data and cell therapy-based diagnostic and therapeutic solutions
|
|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
Detailed competitors of Gene Logic
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gene Logic
Complete news archive for Gene Logic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gene Logic
Gene Logic was founded in 1994 and raised its 1st funding round 2 years after it was founded.
Gene Logic is headquartered in Gaithersburg, United States. It is registered at Gaithersburg, Maryland, United States.
Gene Logic is a funded company, having raised a total of $29M across 2 funding rounds to date.
Gene Logic was founded in 1994 in Gaithersburg, United States, as an integrated genomics firm. Comprehensive genomic reference databases and GLP-compliant microarray services were offered, alongside drug development solutions for the pharmaceutical sector. Involvement in the clinical-stage small molecule candidate GL1001, repositioned for gastrointestinal disease treatment, was noted. The genomic business was acquired by Ocimum Biosolutions in 2007.
Gene Logic's top competitors include Sutro Biopharma, Synthego and Helix.
Gene Logic has 4 investors. Key investors include Goldman Sachs, Hambrecht & Quist, Oxford Bioscience Partners, and Genechem.